PRIMARY STUDY

Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial

Key Findings:  Sixty children diagnosed with ASD and half of them received a CBD-rich cannabis extract while the other a placebo. Resulting data comparing both groups revealed that the CBD-rich cannabis extract improved social interaction, anxiety, psychomotor agitation, and in milder cases of ASD improved the ability to concentrate. Three of the participating pediatric patients experienced adverse effects i.e., dizziness, insomnia, colic and weight gain.